Mirum Pharmaceuticals, Inc. License Agreements
7 Contracts & Agreements
- License Agreement by and between Lumena Pharmaceuticals, Inc. and Sanofi-Aventis Deutschland GmbH, dated September 27, 2012 (Filed With SEC on July 8, 2019)
- License Agreement by and between Lumena Pharmaceuticals, Inc. and Sanofi-Aventis Deutschland GmbH, dated September 27, 2012 (Filed With SEC on June 21, 2019)
- Assignment and License Agreement by and between the Registrant and Shire International GmbH, dated November 5, 2018 (Filed With SEC on June 21, 2019)
- Amendment No. 1 to License Agreement by and between Shire Orphan and Rare Disease GmbH (successor in interest of Lumena Pharmaceuticals, Inc.) and Sanofi-Aventis Deutschland GmbH,... (Filed With SEC on June 21, 2019)
- License Agreement by and between Lumena Pharmaceuticals, Inc. and Pfizer Inc., dated June 1, 2012 (Filed With SEC on June 21, 2019)
- Amendment to License Agreement by and between Lumena Pharmaceuticals, Inc. and Satiogen Pharmaceuticals, Inc., dated February 28, 2011 (Filed With SEC on June 21, 2019)
- License Agreement by and between Lumena Pharmaceuticals, Inc. and Satiogen Pharmaceuticals, Inc., dated February 8, 2011 (Filed With SEC on June 21, 2019)
